Review Article
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis
Table 6
Management strategy of AIP based on immunology therapy.
| Time | 0–12 weeks | 12 weeks–6 months | 6 months–3 years |
| Japan and Asian countries [94] | | | Objective | Induction of remission | Maintenance therapy | Drug | Prednisolone | Prednisolone | Dose | 0.6 mg/Kg/day for 2–4 weeks, tapered by 5 mg every 1-2 weeks to a maintenance dose | 2.5–5.0 mg/day |
| American and European countries [19] | | Objective | Induction of remission | Maintenance therapy | Observation | Drug | Prednisolone | Prednisolone | Immunomodulator/rituximab (when relapsing) | Dose | 30–40 mg/day for 2–4 weeks, tapered by 5 mg every 1-2 weeks to a maintenance dose | 5.0–7.5 mg/day | Undetermined |
|
|